PharmacoEconomics & Outcomes News

, Volume 807, Issue 1, pp 1–1 | Cite as

ICER analysis of CGRP inhibitors for migraine prevention

News item


  1. Institute for Clinical and Economic Review. Institute for Clinical and Economic Review's Final Report on CGRP Inhibitors for Migraine Prevention Explores Specific Coverage Policy Options in Light of Responsible Manufacturer Pricing. Internet Document : 3 Jul 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations